Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Remdesivir

Remdesivir
Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viruses, and is potentially therapeutic against COVID-19.
Catalog No. T7766Cas No. 1809249-37-3
Select Batch
Purity:100%
Contact us for more batch information

Resource Download

Remdesivir

Catalog No. T7766Alias GS-5734Cas No. 1809249-37-3

Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viruses, and is potentially therapeutic against COVID-19.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$122In Stock
5 mg$339In Stock
10 mg$537In Stock
25 mg$797In Stock
50 mg$1,120In Stock
100 mg$1,510In Stock
200 mg$1,990In Stock
1 mL x 10 mM (in DMSO)$450In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Remdesivir"

Product Introduction

Bioactivity
Description
Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viruses, and is potentially therapeutic against COVID-19.
Targets&IC50
SARS-CoV:74 nM (EC50) , MERS-CoV:74 nM (EC50)
In vitro
METHODS: Mouse hepatitis virus (MHV)-infected DBT cells were incubated with Remdesivir (0.01-1 µM) for 24 h, and the supernatant was analyzed for viral titer by plaque assay.
RESULTS: Remdesivir effectively inhibited MHV with an EC50 of 0.03 µM. [1]
METHODS: 2019-nCoV-infected Vero E6 cells were treated with Remdesivir (0-400 µM) for 48 h. Viral yield in cell supernatants was detected using qRT-PCR.
RESULTS: Remdesivir effectively blocked viral infection at low micromolar concentrations and showed high SI (EC50 = 0.77 μM; CC50 > 100 μM; SI > 129.87). [2]
In vivo
METHODS: To assay antiviral activity in vivo, Remdesivir (25 mg/kg, 12% sulfobutylether-β-cyclodextrin sodium salt in water (with HCl/NaOH) at pH 5.0) was injected subcutaneously into MERS-CoV-infected Ces1c-/- hDPP4 mice twice daily.
RESULTS: Prophylactic Remdesivir reduced MERS-CoV replication and disease. [3]
METHODS: To assay antiviral activity in vivo, Remdesivir (25 mg/kg once daily, administered three times) and Loratadine (10 mg/kg once daily, administered four times) were administered intraperitoneally to 501Y.V2 SARS-CoV-2 infected BALB/c mice.
RESULTS: The combination of Remdesivir and the antihistamine Loratadine reduced SARS-CoV-2 replication and inflammation and protected against lung injury. [4]
AliasGS-5734
Chemical Properties
Molecular Weight602.58
FormulaC27H35N6O8P
Cas No.1809249-37-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 12.5 mg/mL (20.74 mM), Suspension. Working solution is recommended to be prepared and used immediately.
DMSO: 50 mg/mL (82.98 mM)
Solution Preparation Table
10% DMSO+40% PEG300+5% Tween 80+45% Saline/DMSO
1mg5mg10mg50mg
1 mM1.6595 mL8.2977 mL16.5953 mL82.9765 mL
5 mM0.3319 mL1.6595 mL3.3191 mL16.5953 mL
10 mM0.1660 mL0.8298 mL1.6595 mL8.2977 mL
20 mM0.0830 mL0.4149 mL0.8298 mL4.1488 mL
DMSO
1mg5mg10mg50mg
50 mM0.0332 mL0.1660 mL0.3319 mL1.6595 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Remdesivir | purchase Remdesivir | Remdesivir cost | order Remdesivir | Remdesivir chemical structure | Remdesivir in vivo | Remdesivir in vitro | Remdesivir formula | Remdesivir molecular weight